ENDOCARDIAL SOLUTIONS INC [Rocket]

In millions, except per share items	Dec-31-03	Dec-31-02	Dec-31-01	Dec-31-00	Dec-31-99	Dec-31-98	Dec-31-97
	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K
Revenues	36.6	26.3	22.9	14.6	9.6	2.0	0.0
Revenue growth	39.2%	14.7%	57.2%	51.7%	392.0%
Cost of goods sold	12.2	9.5	9.2	7.2	6.6	3.6	0.0
Gross profit	24.3	16.8	13.7	7.4	3.0	-1.7	0.0
Gross margin	66.5%	63.9%	59.6%	50.7%	31.3%	-85.8%
Selling, general and administrative [+]	23.0	21.1	17.0	13.1	9.7	3.1	2.9
Sales and marketing	19.9	18.1	14.8	11.1	7.7	1.3	0.8
General and administrative	3.1	3.0	2.2	2.1	2.0	1.8	2.1
Research and development	5.6	5.5	5.3	4.5	5.1	10.7	6.7
Other operating expenses	0.0	0.0	0.0	0.0
EBITDA [+]	-3.3	-8.6	-6.9	-8.7	-11.0	-14.8
EBITDA growth	-60.9%	24.0%	-20.7%	-20.9%	-25.6%
EBITDA margin	-9.1%	-32.6%	-30.2%	-59.8%	-114.7%	-758.3%
Depreciation and amortization	1.0	1.3	1.7	1.5	0.8	0.6
EBIT [+]	-4.4	-9.9	-8.6	-10.2	-11.8	-15.4	-9.7
EBIT growth	-55.9%	14.7%	-15.8%	-13.4%	-23.3%	59.2%
EBIT margin	-11.9%	-37.6%	-37.6%	-70.2%	-123.1%	-790.1%
Pre-tax income	-4.5	-10.0	-8.5	-10.3	-11.7	-14.7	-8.6
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-4.5	-10.0	-8.5	-10.3	-11.7	-14.7	-8.6
Net margin	-12.2%	-37.9%	-37.0%	-70.8%	-122.2%	-752.9%

Basic EPS [+]	($0.22)	($0.61)	($0.60)	($0.92)	($1.23)	($1.63)	($1.21)
Growth	-64.1%	2.3%	-35.1%	-25.0%	-24.9%	34.9%
Diluted EPS [+]	($0.22)	($0.61)	($0.60)	($0.92)	($1.23)	($1.63)	($1.21)
Growth	-64.1%	2.3%	-35.1%	-25.0%	-24.9%	34.9%

Shares outstanding (basic) [+]	20.3	16.3	14.2	11.2	9.6	9.0	7.1
Growth	24.5%	14.9%	26.7%	17.3%	6.3%	27.2%
Shares outstanding (diluted) [+]	20.3	16.3	14.2	11.2	9.6	9.0	7.1
Growth	24.5%	14.9%	26.7%	17.3%	6.3%	27.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.